1. Home
  2. NVCR vs MNR Comparison

NVCR vs MNR Comparison

Compare NVCR & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • MNR
  • Stock Information
  • Founded
  • NVCR 2000
  • MNR 2017
  • Country
  • NVCR Switzerland
  • MNR United States
  • Employees
  • NVCR N/A
  • MNR N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • MNR
  • Sector
  • NVCR Health Care
  • MNR
  • Exchange
  • NVCR Nasdaq
  • MNR Nasdaq
  • Market Cap
  • NVCR 1.9B
  • MNR 1.6B
  • IPO Year
  • NVCR 2015
  • MNR 2023
  • Fundamental
  • Price
  • NVCR $17.37
  • MNR $14.06
  • Analyst Decision
  • NVCR Buy
  • MNR Strong Buy
  • Analyst Count
  • NVCR 6
  • MNR 3
  • Target Price
  • NVCR $32.83
  • MNR $24.00
  • AVG Volume (30 Days)
  • NVCR 861.0K
  • MNR 157.7K
  • Earning Date
  • NVCR 04-24-2025
  • MNR 05-13-2025
  • Dividend Yield
  • NVCR N/A
  • MNR 20.43%
  • EPS Growth
  • NVCR N/A
  • MNR 163.54
  • EPS
  • NVCR N/A
  • MNR 1.90
  • Revenue
  • NVCR $621,711,000.00
  • MNR $942,808,000.00
  • Revenue This Year
  • NVCR $2.90
  • MNR $5.81
  • Revenue Next Year
  • NVCR $10.47
  • MNR $0.18
  • P/E Ratio
  • NVCR N/A
  • MNR $7.09
  • Revenue Growth
  • NVCR 18.27
  • MNR 40.06
  • 52 Week Low
  • NVCR $14.17
  • MNR $12.40
  • 52 Week High
  • NVCR $34.13
  • MNR $20.96
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 50.16
  • MNR 52.75
  • Support Level
  • NVCR $16.19
  • MNR $13.19
  • Resistance Level
  • NVCR $17.70
  • MNR $13.88
  • Average True Range (ATR)
  • NVCR 0.83
  • MNR 0.38
  • MACD
  • NVCR 0.07
  • MNR 0.08
  • Stochastic Oscillator
  • NVCR 50.69
  • MNR 62.77

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About MNR Mach Natural Resources LP

Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.

Share on Social Networks: